DRAVP ID Peptide Name Source Target Organism Patent No
DRAVPa1801 Sequence 22 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1802 Sequence 23 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1803 Sequence 24 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1804 Sequence 25 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1805 Sequence 26 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1806 Sequence 27 from Patent US20040229219 A1 Mouse hepatitis virus SARS US20040229219 A1
DRAVPa1807 Sequence 28 from Patent US20040229219 A1 Human immunodeficiency virus type 1 SARS US20040229219 A1
DRAVPa1808 Sequence 29 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1809 Sequence 30 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1810 Sequence 31 from Patent US20040229219 A1 Human immunodeficiency virus type 1 SARS US20040229219 A1
DRAVPa1811 Sequence 32 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1812 Sequence 33 from Patent US20040229219 A1 Mouse hepatitis virus SARS US20040229219 A1
DRAVPa1813 Sequence 34 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1814 Sequence 35 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1815 Sequence 36 from Patent US20040229219 A1 Human metapneumovirus SARS US20040229219 A1
DRAVPa1816 Sequence 38 from Patent US20040229219 A1 Human immunodeficiency virus type 1 SARS US20040229219 A1
DRAVPa1817 Sequence 39 from Patent US20040229219 A1 Homo sapiens SARS US20040229219 A1
DRAVPa1818 Sequence 40 from Patent US20040229219 A1 Mouse hepatitis virus SARS US20040229219 A1
DRAVPa1819 Sequence 41 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1820 Sequence 42 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
First 88 89 90 91 92 93 94 Last